Cormorant Asset Management »

Amylyx Pharmaceuticals shares owned by Cormorant Asset Management

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by Cormorant Asset Management from 13F filings

Historical chart of Cormorant Asset Management investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by Cormorant Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.8M 400k 12.08
2025-09-30 $6.8M 500k 13.59
2022-12-31 $20M 550k 36.95
2022-09-30 $17M 610k 28.15

More positions owned by Cormorant Asset Management

Praxis Precision Medicines I Com New (PRAX)
Bridgebio Oncology Therapeut Com New (BBOT)
Abivax Sa Sponsored Ads (ABVX)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Eyepoint Com New (EYPT)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Spdr Series Trust State Street Spd Put Option (XBI)
Rapport Therapeutics (RAPP)
Bridgebio Pharma (BBIO)
Bright Minds Biosciences Com New (DRUG)
Edgewise Therapeutics (EWTX)
Olema Pharmaceuticals (OLMA)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Insmed Com Par $.01 (INSM)
Engene Holdings (ENGN)

View all positions for Cormorant Asset Management

Top funds holding Amylyx Pharmaceuticals

FMR
BlackRock
Perceptive Advisors
Adage Capital Partners GP
TCG Crossover Management
Vanguard Group
Commodore Capital
Saturn V Capital Management
First Light Asset Management
Goldman Sachs Group
Henderson Group
Driehaus Capital Management
Geode Capital Management
Almitas Capital
State Street Corporation

View all funds holding Amylyx Pharmaceuticals